Similarly, Vu et al reported that SYNCRIP is a new RNA‐binding protein that controls the myeloid leukaemia stem cell programme, and its depletion increases apoptosis and differentiation while delaying leukemogenesis.41 The gene discussed is SYNCRIP; the disease is myeloid leukemia.